Guillain-Barré syndrome has happened in people treated with TIBSOVO. Your healthcare provider will monitor you for nervous system problems and will permanently stop your treatment with …

TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with bile duct cancer (cholangiocarcinoma) that has spread and who have …

TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with myelodysplastic syndromes (MDS) when the disease has come back or …

TIBSOVO is a targeted therapy—a personalized treatment option that targets a specific type of mutation known as IDH1. About 6% to 16% of people with AML have the IDH1 mutation.

TIBSOVO is a targeted therapy that works against a mutation called the IDH1 mutation. The IDH1 mutation plays an important role in the development of AML because it prevents myeloblasts from becoming healthy white blood cells.

Learn about taking TIBSOVO® alone, or in combination with azacitidine, and possible side effects. See full indication, prescribing information, & Boxed Warning.

Co-administration of TIBSOVO may decrease the concentrations of hormonal contraceptives, consider alternative methods of contraception in patients receiving TIBSOVO.

TIBSOVO® (tib-SOH-voh) (ivosidenib tablets) What is the most important information I should know about TIBSOVO? ifferentiation Syndrome. Differentiation syndrome is a common …

TIBSOVO is a pill that's typically prescribed for patients to take 2 tablets once a day. You can take TIBSOVO at home with or without food and without the infusion time requirements of …

TIBSOVO is an oral prescription medicine used to treat advanced bile duct cancer/cholangiocarcinoma (CCA) in adult patients who have already received previous …